Attached files

file filename
EX-99.1 - EX-99.1 - SYNOVIS LIFE TECHNOLOGIES INCc56812exv99w1.htm
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 4, 2010
SYNOVIS LIFE TECHNOLOGIES, INC.
(Exact name of Registrant as specified in its charter)
State of Incorporation: Minnesota
Commission File No.: 0-13907
I.R.S. Employer Identification No.: 41-1526554
Address of principal executive offices:
2575 University Ave. W.
St. Paul, Minnesota 55114
Telephone Number: (651) 796-7300
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 5.07 Submission of Matters to a Vote of Security Holders.
On March 4, 2010, Synovis Life Technologies, Inc. (the “Company”) held its Annual Meeting of Shareholders for the following purposes:
  1)   To elect eight (8) directors to hold office until the next Annual Meeting of Shareholders or until their successors are duly elected and qualified.
 
  2)   To consider and act upon a proposal to amend the Company’s Employee Stock Purchase Plan (the “ESPP”) to increase the number of shares of the Company’s common stock, $.01 par value per share, specifically reserved for issuance under the ESPP by 100,000 shares.
 
  3)   To consider a proposal to ratify the selection of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending October 31, 2010.
All proposals were approved by the shareholders. The results of each voting proposal were as follows:
  (1)   Election of Directors
                         
Nominee   For     Withheld     Broker Non-Votes  
William G. Kobi
    6,221,727       121,678       3,348,814  
Richard W. Kramp
    6,221,765       121,640       3,348,814  
Karen Gilles Larson
    6,201,143       142,262       3,348,814  
Mark F. Palma
    6,217,581       125,824       3,348,814  
Richard W. Perkins
    5,790,609       552,796       3,348,814  
Timothy M. Scanlan
    6,221,309       122,096       3,348,814  
John D. Seaberg
    5,866,202       477,203       3,348,814  
Sven A. Wehrwein
    5,357,538       985,867       3,348,814  
  (2)   Proposal to amend the Company’s ESPP
             
For   Against   Abstentions   Broker Non-Votes
5,744,584
  547,097   51,724   3,348,814
  (3)   Proposal to ratify Grant Thornton LLP as Independent Registered Public Accounting Firm
             
For   Against   Abstentions   Broker Non-Votes
9,119,974   518,773   53,472   -0-
Item 8.01. Other Events.
On March 8, 2010, the Company announced in a press release that its board of directors approved a stock repurchase program whereby the Company has been authorized to repurchase up to 1,000,000 shares of its common stock in the open market or in private transactions. A copy of the press release announcing this action is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
     (d) Exhibits.

 


 

         
Exhibit No.   Description
  99.1    
Press Release dated March 8, 2010 (filed herewith).

 


 

Signature
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
         
  SYNOVIS LIFE TECHNOLOGIES, INC.
 
 
Dated: March 8, 2010  By:   /s/ Brett Reynolds    
    Brett Reynolds
Vice-President of Finance, Chief
Financial Officer and Corporate
Secretary
 
       

 


 

         
SYNOVIS LIFE TECHNOLOGIES, INC.
FORM 8-K
INDEX TO EXHIBITS
         
Exhibit No.   Description
  99.1    
Press Release dated March 8, 2010 (filed herewith).